Hitoshi Matsumoto
Tokushima Bunri University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hitoshi Matsumoto.
Bioorganic & Medicinal Chemistry | 2000
Hiroyuki Nakano; Tsutomu Inoue; Nobuhide Kawasaki; Hideki Miyataka; Hitoshi Matsumoto; Takeo Taguchi; Naoki Inagaki; Hiroichi Nagai; Toshio Satoh
Novel benzimidazole derivatives were synthesized and their pharmacological activities were examined. These compounds showed a good suppressive action on histamine release from rat peritoneal mast cells produced by antigen-antibody reaction, an antagonistic action on guinea pig ileum contraction caused by histamine, an inhibitory action on 5-lipoxygenase in rat basophilic leukemia-1 (RBL-1) cells, and a preventive action on NADPH dependent lipid peroxidation induced by Fe3+-ADP in rat liver microsomes. In addition, 1-[2-[2-(4-Hydroxy-2,3,5-trimethylphenoxy)ethoxy]-ethyl]-2-(4-meth yl-1-homopiperazino)-1H-benzimidazole difumarate (BOM1006) exhibited a dose dependent suppressive action on 48 h homologous passive cutaneous anaphylaxis (PCA) reaction in rats orally administered the drug.
International Journal of Pharmaceutics | 1997
Teruko Imai; Katsuhiko Nodomi; Mohammed Shameem; Hitoshi Matsumoto; Toshio Satoh; Masaki Otagiri
Abstract We studied the dissolution behavior and oral absorption of dl-α-tocopherol (VE) from solid dispersions of egg albumin in the presence or absence of a series of saturated fatty acids. The solubility diagram of VE–egg albumin was of the Bs-type. The solubility of VE was increased by 300-fold in the presence of egg albumin. The egg albumin complex of the drug was obtained in a molar ratio of 20:1 (VE:egg albumin) from the aqueous solubility diagram. The apparent dissolution rate of VE from solid dispersion with egg albumin was markedly enhanced in comparison with VE alone. Addition of various fatty acids to VE–egg albumin solid dispersions had different effects on the dissolution of VE due to mutual effect of fatty acid and egg albumin. Myristic acid was found to improve the dissolution of VE maximally, while capric acid decreased the solubility of VE obtained from egg albumin solid dispersion. The mean serum levels of VE following oral administration of egg albumin solid dispersions, especially egg albumin solid dispersion containing myristic acid, were significantly higher than those of the drug alone. No significant differences were found between the mean residence times of drug and its solid dispersions. In addition, degradation of VE was inhibited by dispersion in egg albumin.
Chemical & Pharmaceutical Bulletin | 1992
Hisao Kakegawa; Hitoshi Matsumoto; Toshio Satoh
Biological & Pharmaceutical Bulletin | 1997
Hideki Miyataka; Mayumi Nishiki; Hitoshi Matsumoto; Takunori Fujimoto; Mitsuo Matsuka; Toshio Satoh
Biological & Pharmaceutical Bulletin | 1994
Satoshi Sogawa; Yasunori Nihro; Hiroki Ueda; Tokutaro Miki; Hitoshi Matsumoto; Toshio Satoh
Chemical & Pharmaceutical Bulletin | 1994
Yasunori Nihro; Haruhiro Furukawa; Satoshi Sogawa; Tzer Chuan Wang; Hideki Miyataka; Hitoshi Matsumoto; Tokutaro Miki; Toshio Satoh
Chemical & Pharmaceutical Bulletin | 1991
Yasunori Nihro; Satoshi Sogawa; Tadamitsu Sudo; Tokutaro Miki; Hitoshi Matsumoto; Toshio Satoh
Biological & Pharmaceutical Bulletin | 1996
Yasuhiro Tsuji; Hisao Kakegawa; Hideki Miyataka; Mayumi Nishiki; Hitoshi Matsumoto; Toshio Satoh
Journal of Pharmaceutical Sciences | 2005
Masao Takei; Akemi Umeyama; Shigenobu Arihara; Hitoshi Matsumoto
Chemical & Pharmaceutical Bulletin | 1994
Tzer Chuan Wang; Haruhiro Furukawa; Yasunori Nihro; Hisao Kakegawa; Hitoshi Matsumoto; Toshio Satoh